These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28688469)

  • 1. Financial Conflict of Interest and Academic Influence Among Experts Speaking on Behalf of the Pharmaceutical Industry at the US Food and Drug Administration's Oncologic Drugs Advisory Committee Meetings.
    Lammers A; Edmiston J; Kaestner V; Prasad V
    Mayo Clin Proc; 2017 Jul; 92(7):1164-1166. PubMed ID: 28688469
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncologic Drugs Advisory Committee and conflicts of interest.
    Burki TK
    Lancet Oncol; 2016 Mar; 17(3):e95. PubMed ID: 26877161
    [No Abstract]   [Full Text] [Related]  

  • 3. Financial Conflicts of Interest at FDA Drug Advisory Committee Meetings.
    Hayes MJ; Prasad V
    Hastings Cent Rep; 2018 Mar; 48(2):10-13. PubMed ID: 29590518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probity gone nuts.
    Nat Biotechnol; 2007 May; 25(5):483. PubMed ID: 17483818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and Conflicts of Public Speakers at Meetings of the Oncologic Drugs Advisory Committee to the US Food and Drug Administration.
    Abola MV; Prasad V
    JAMA Intern Med; 2016 Mar; 176(3):389-91. PubMed ID: 26831527
    [No Abstract]   [Full Text] [Related]  

  • 6. The Potential Effects of Financial Conflicts of Interest of Speakers at the US Food and Drug Administration's Pulmonary-Allergy Drug Advisory Committee Meetings.
    Bickford T; Kinder N; Arthur W; Wayant C; Vassar M
    Chest; 2021 Jun; 159(6):2399-2401. PubMed ID: 33171160
    [No Abstract]   [Full Text] [Related]  

  • 7. Financial conflicts of interest and the Food and Drug Administration's Advisory Committees.
    Steinbrook R
    N Engl J Med; 2005 Jul; 353(2):116-8. PubMed ID: 16014880
    [No Abstract]   [Full Text] [Related]  

  • 8. Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings.
    Lurie P; Almeida CM; Stine N; Stine AR; Wolfe SM
    JAMA; 2006 Apr; 295(16):1921-8. PubMed ID: 16639051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and conflicts of interests of public speakers at the Psychopharmacologic Drug and Advisory Committee meetings regarding psychiatric drugs.
    Roberts W; Jellison S; Wayant C; Vassar M
    BMJ Evid Based Med; 2020 Aug; 25(4):145-146. PubMed ID: 32019896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Settling for second best?
    Pitts PJ
    Nat Biotechnol; 2007 Jul; 25(7):715-6. PubMed ID: 17621285
    [No Abstract]   [Full Text] [Related]  

  • 11. Hidden conflicts?
    Piller C
    Science; 2018 Jul; 361(6397):16-20. PubMed ID: 29976808
    [No Abstract]   [Full Text] [Related]  

  • 12. Conflicts of Interest Among Patient and Consumer Representatives to U.S. Food and Drug Administration Drug Advisory Committees.
    Graham SS; Card DJ; Ahn S; Kim SY; Kessler MM; Olson MK
    Ann Intern Med; 2016 Oct; 165(8):606-607. PubMed ID: 27750309
    [No Abstract]   [Full Text] [Related]  

  • 13. When is a point of view a conflict of interest?
    Lenzer J
    BMJ; 2016 Nov; 355():i6194. PubMed ID: 27881367
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C drug maker puts profit ahead of patients, US Senate report charges.
    McCarthy M
    BMJ; 2015 Dec; 351():h6573. PubMed ID: 26635239
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of Appearance of Conflicts of Interest With Voting Behavior at FDA Advisory Committee Meetings-A Cross-sectional Study.
    Xu J; Emenanjo O; Ortwerth M; Lurie P
    JAMA Intern Med; 2017 Jul; 177(7):1038-1040. PubMed ID: 28464118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immoral experts?].
    Cannasse S
    Rev Prat; 2014 Jan; 64(1):3. PubMed ID: 24649532
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential Financial Bias From Speakers at US Food and Drug Administration's Bone, Reproductive, and Urologic Drugs Advisory Committee Meetings.
    Johnson BS; Roberts W; Riddle J; Wayant C; Scott J; Vassar M
    Urology; 2020 Mar; 137():1-6. PubMed ID: 31911084
    [No Abstract]   [Full Text] [Related]  

  • 18. What's wrong with money in science.
    Stossel T; Shaywitz D
    Washington Post; 2006 Jul; ():B3. PubMed ID: 16838447
    [No Abstract]   [Full Text] [Related]  

  • 19. Advisory committees at FDA: the Hinchey Amendment and "conflict of interest" waivers.
    Lietzan E
    J Health Law; 2006; 39(4):415-49. PubMed ID: 17402656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review.
    Nejstgaard CH; Bero L; Hróbjartsson A; Jørgensen AW; Jørgensen KJ; Le M; Lundh A
    BMJ; 2020 Dec; 371():m4234. PubMed ID: 33298430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.